15. Prior MI
CAD, no MICAD RF only
Circ Cardiovasc Qual
Outcomes 2014;7:1-11
16. “Beta-blocker use at discharge in patients with stable angina without
prior history of MI or systolic HF undergoing elective PCI was not
associated with any decrease in mortality, revascularization and re-
hospitalization related to MI or stroke at 30-days and 3-years follow-
up,” Parikh concluded. “Over time, prescriptions of beta-blockers at
discharge have continued to increase in this population despite of
lack of clearly demonstrated objective benefits.”
19. 1. All post MI pts, up to 3 years
2. All patients with LVEF < 0.40
20. 1. Fails to reduce central aortic pressure
2. Increase in unfavorable metabolic
consequence – DM, dyslipidemia
3. Unable to provide benefit in the era of
thrombolysis & revascularization / anti-
platelets / ACE-I / Statins
4. Not well tolerated and poor adherence to Rx
NB: 4th line of Rx in hypertension
21. 1. Post MI group (up to 3 years)
2. CHF with LV systolic dysfunction
?? may consider for angina relief
